Search Results - Enjeti, A.K.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles

    The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles by ALKHATATBEH, M. J., MHAIDAT, N. M., ENJETI, A. K., LINCZ, L. F., THORNE, R. F.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)

    PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC):... by Ito, T., Sanford, D., Tomuleasa, C., Hsiao, H.H., Enciso Olivera, L.J., Enjeti, A.K., Gimenez, Conca A, Bernal del Castillo, T., Girshova, L., Martelli, M.P., Guvenc, B., Bui, C.N., Delgado, A., Duan, Y., Garbayo Guijarro, B., Llamas, C., Lee, J.H.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL

    SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, E.K., Johnston, A.J., Pati, N., Hawkes, E., Lee, H., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B.E., Trotman, J.

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Circulating plasma CD36+ microparticles as a marker of type 2 diabetes and its complications

    Circulating plasma CD36+ microparticles as a marker of type 2 diabetes and its complications by Alkhatatbe, M.J., Mhaidat, N.M., Enjeti, A.K., Lincz, L.F., Thorne, R.F.

    Published in Clinical biochemistry
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PS1068 SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

    PS1068 SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUS... by Verner, E., Johnston, A., Pati, N., Hawkes, E., Lee, H.P., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Sia, H., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B., Trotman, J.

    Published in HemaSphere
    Request full text
    Article
    Save to List
    Saved in:
  6. 6
    SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL

    SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, E.K., Johnston, A.J., Pati, N., Hawkes, E., Lee, H., Cochrane, T., Cheah, C.Y., Filshie, R., Purtill, D., Enjeti, A.K., Brown, C., Murphy, N., Curnow, J., Cake, S., Carlson, J., Butcher, B.E., Trotman, J.

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: